Malignant Pleural Mesothelioma: First Chemotherapy or first Surgery?

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
ZENTRALBLATT FUR CHIRURGIE | 2019年 / 144卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Survival Benefit of Multiagent Chemotherapy With and Without Curative Surgery for Malignant Pleural Mesothelioma
    Alnajar, A.
    Rodriguez, E.
    Razi, S.
    Nguyen, D.
    Villamizar, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S897 - S898
  • [42] Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review
    Dawson, Alan G.
    Kutywayo, Kudzayi
    Mohammed, Seid B.
    Fennell, Dean A.
    Nakas, Apostolos
    THORAX, 2023, 78 (04) : 409 - 417
  • [43] First-Line Nivolumab plus Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
    Baas, P.
    Scherpereel, A.
    Nowak, A.
    Fujimoto, N.
    Peters, S.
    Tsao, A.
    Mansfield, A.
    Popat, S.
    Jahan, T.
    Antonia, S.
    Oulkhouir, Y.
    Bautista, Y.
    Cornelissen, R.
    Greillier, L.
    Grossi, F.
    Kowalski, D. M.
    Rodriguez-Cid, J.
    Aanur, P.
    Baudelet, C.
    Zalcman, G.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (10) : E42 - E42
  • [44] Liposomal doxorubicin and cisplatin as first-line chemotherapy in unresectable malignant pleural mesothelioma: A phase II study
    Arrieta, O., Sr.
    Medina, L. A., Sr.
    Guzman, E.
    Rios Trejo, M. A., Sr.
    Mendoza, D.
    Atorga Ramos, A.
    Martinez Barrera, L.
    Hernandez Pedro, N.
    Arechaga Ocampo, E.
    De la Garza, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Liposomal doxorubicin and cisplatin as first-line chemotherapy in unresectable malignant pleural mesothelioma: A phase II study
    Arrieta, Oscar
    Medina, Luis A.
    Guzman, Enrique
    Rios-Trejo, Miguel A.
    Villanueva, Geraldine
    Mendoza, Daniel
    Astorga-Ramos, Alma M.
    Martinez-Barrera, Luis
    Hernandez-Pedro, Norma
    Arechaga-Ocampo, Elena
    de la Garza, Jamie
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S779 - S779
  • [46] Life after First-line Chemotherapy in Malignant Pleural Mesothelioma: a North-East England Experience
    Steer, J.
    Bough, G.
    Razak, A. R. A.
    Meachery, G. J.
    Hughes, A.
    CLINICAL ONCOLOGY, 2010, 22 (03) : 231 - 235
  • [47] Prognostic Factors in Malignant Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: A Baseline Risk Score
    Guijosa, A.
    Munoz-Montano, W.
    Trejo-Rosales, R.
    Gomez-Garcia, A. P.
    Cabrera-Miranda, L. A.
    Flores, D.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S684 - S684
  • [48] Outcomes of patients with malignant pleural mesothelioma treated with first line palliative cisplatin and pemetrexed chemotherapy, in South Yorkshire
    Taylor, F.
    Viggars, A.
    Daniels, S.
    Danson, S. J.
    Fisher, P. M.
    Hatton, M. Q.
    Lee, C. E.
    Woll, P. J.
    LUNG CANCER, 2015, 87 : S20 - S20
  • [49] Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
    Woodard, Gavitt A.
    Jablons, David M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 : S86 - S91
  • [50] Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma
    de Bree, E
    van Ruth, S
    Baas, P
    Rutgers, EJT
    van Zandwijk, N
    Witkamp, AJ
    Zoetmulder, FAN
    CHEST, 2002, 121 (02) : 480 - 487
12345